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Abstract
Background:  The interpretability of microarray data can be affected by sample quality. To
systematically explore how RNA quality affects microarray assay performance, a set of rat liver
RNA samples with a progressive change in RNA integrity was generated by thawing frozen tissue
or by ex vivo incubation of fresh tissue over a time course.
Results: Incubation of tissue at 37°C for several hours had little effect on RNA integrity, but did
induce changes in the transcript levels of stress response genes and immune cell markers. In
contrast, thawing of tissue led to a rapid loss of RNA integrity. Probe sets identified as most
sensitive to RNA degradation tended to be located more than 1000 nucleotides upstream of their
transcription termini, similar to the positioning of control probe sets used to assess sample quality
on Affymetrix GeneChip® arrays. Samples with RNA integrity numbers less than or equal to 7
showed a significant increase in false positives relative to undegraded liver RNA and a reduction in
the detection of true positives among probe sets most sensitive to sample integrity for in silico
modeled changes of 1.5-, 2-, and 4-fold.
Conclusion: Although moderate levels of RNA degradation are tolerated by microarrays with 3'-
biased probe selection designs, in this study we identify a threshold beyond which decreased
specificity and sensitivity can be observed that closely correlates with average target length. These
results highlight the value of annotating microarray data with metrics that capture important
aspects of sample quality.
Background
It is recommended that the highest quality RNA be used
for genomic analyses. However, in some cases, such as
human autopsy samples or paraffin embedded tissues,
high quality RNA samples may not be available. It is there-
fore important to understand how RNA quality affects the
interpretation of the results and also how reliable current
quality measures are at indicating RNA quality issues. It
has been reported that gene expression profiling on
Affymetrix GeneChip arrays is relatively tolerant to mod-
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erate RNA degradation and to the 5'-truncation that
occurs during the two successive rounds of in vitro tran-
scription needed to detect small sample quantities [1-3].
Some samples fall within a "grey zone" of sample quality,
where there is some loss of RNA integrity but the samples
still pass RNA quality thresholds. It is unknown how dif-
ferences in RNA integrity within the "grey zone" affect the
data interpretation. More information is needed to help
guide the generation of best practice recommendations
for sample handling and the evaluation of the quality of
genomic studies submitted to public databases to fulfill
journal requirements and to regulatory agencies.
The recommended method for preparing target from RNA
for hybridization to Affymetrix microarrays is based on
the Eberwine procedure [4]. The sample labeling and
amplification method starts with cDNA synthesis from
the polyadenylation (polyA) site followed by the genera-
tion of cRNA from the sense strand of the cDNA via an
incorporated T7 primer sequence. Because this process
generates labeled target with a 3' bias, Affymetrix Gene-
Chip Rat Expression Set 230 (RAE230A) arrays are
designed to contain probes that reside within the 600
nucleotides (nt) most proximal to the 3' end of each tran-
script [5]. Where alternative polyA sites are identified
within 600 nt of each other, the probe selection region is
based on the most upstream site. The housekeeping genes
beta-actin (Actb) and glyceraldehyde-3-phosphate dehy-
drogenase (Gapdh) serve as internal controls of RNA qual-
ity and the target preparation process. Probe sets have
been designed to hybridize to the 5', middle (M), or 3'-
regions of these control transcripts. High signal ratios of
the 3' probe set to the 5' probe set are indicative of either
RNA degradation or target synthesis problems. It has been
recommended that samples should have a 3'/5' signal
ratio for Gapdh of no more than 3 [6].
Various methods for measuring sample quality pre- and
post-hybridization have been proposed [7-10]. In this
study the degree of RNA degradation was standardized by
use of an Agilent 2100 Bioanalyzer to assign an RNA
integrity number (RIN) to each sample. The RIN software
algorithm classifies the integrity of eukaryotic total RNA
on a scale of 1 to 10 (most to least degraded) based on the
most informative features of an electropherogram of the
18s and 28s rRNA peaks [11].
In this study a set of rat liver samples with a progressive
loss in RNA quality was generated. This dataset was used
to characterize individual probe set sensitivity to RNA
degradation and to evaluate the effect of RNA integrity on
the sensitivity and specificity of microarray data generated
on Affymetrix GeneChip arrays.
Results
Effect of sample handling on RNA integrity
The methods used to harvest and preserve source tissue for
gene expression analyses can impact the quality of iso-
lated mRNA and the reliability of microarray data gener-
ated from this source. We investigated the relative impact
of several different tissue handling conditions on RNA
integrity. These conditions were designed to model the
effect of time between necropsy or sacrifice and sample
processing (incubation at room temperature or 37°C) or
between removal from storage and sample processing
(time of thaw of frozen sample). Fresh liver tissue was
incubated up to 6 hr at room temperature without a meas-
urable effect on RNA integrity, as measured by RIN (Figure
1). RNA in fresh liver tissue proved to be remarkably sta-
ble. RNA degradation was only observed after fresh liver
tissue was incubated at 37°C for 120 min or more and
poor quality RNA (RIN ≤ 7) appeared after 3.5 hours of
incubation at 37°C. RNA degradation was much more
rapid in frozen tissue. Poor quality RNA (RIN ≤ 7) was iso-
lated from frozen tissue thawed for 15–30 min at room
temperature.
Sample characterization by RNA quality metrics
For each of the sample handling conditions that induced
RNA degradation (37°C incubation or freeze/thaw (F/T)),
sets of progressively degraded RNA were generated in
independent experiments, with each experiment using a
Time course of RNA degradation induced by different tissue  handling conditions Figure 1
Time course of RNA degradation induced by differ-
ent tissue handling conditions. RNA was prepared from 
liver sections incubated at room temperature (RT) (circles), 
37°C (triangles), or frozen and thawed at room temperature 
(F/T) (squares). The dotted line represents the linear trend-
line for the RT incubated sample set. Dashed or solid lines 
connect the mean values at hourly or semi-hourly time 
points for the 37°C or F/T handling condition sets, respec-
tively. Symbol shading indicates replicate experiments con-
ducted on different days from independent sources of tissue.BMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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Electrophoretic tracings of RNA progressively degraded by different handling methods Figure 2
Electrophoretic tracings of RNA progressively degraded by different handling methods. Rescaled tracings were 
overlaid from three RNA samples from independent experiments with similar RIN values. Tracings for RNA from samples 
degraded by freeze/thaw (A, C, E, G) or by 37°C incubation (B, D, F, H) and with values of RIN 9.5 (A and B), RIN 8 (C and D), 
RIN 7 (E and F), or RIN 6 (G and H) are shown.BMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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single liver lobe from a different individual animal as
source tissue. Each of these sets contains a minimum of 12
RNA samples across three or more replicate experiments
with RIN values ranging from 9.5 to 5. Electrophoretic
tracings of RNA with RIN measurements of 9.5, 8, 7, or 6
are shown in Figure 2 for three independent samples in
each sample handling set. The tracings are highly similar
between samples with the same RIN, but show subtle dif-
ferences between the two handling methods for a given
RIN value. Within each handling condition, 3 samples
with similar RIN values were grouped as replicate samples
in all additional analyses on the effects of RNA degrada-
tion.
Next, the relationship was examined between RIN and 3
other RNA quality metrics (28s/18s rRNA ratio, cRNA
yield, and cRNA length) that are generated before or dur-
ing microarray sample preparation (Table 1). Of these 3
metrics, RIN value was most highly correlated with aver-
age cRNA length across a set of 29 samples generated from
both handling methods (r = 0.86). RIN values also corre-
lated fairly well with cRNA yield and with 28s/18s ribos-
omal RNA ratios (r = 0.84 and r = 0.82, respectively).
Some differences in the correspondence between RIN
value and the other 3 RNA metrics were observed between
the two different handling methods. In general, there was
a stronger decreasing trend in metric value as a function of
RIN for RNA degraded by F/T than for RNA degraded by
37°C incubation.
Microarray quality metrics and signal changes induced by 
RNA degradation
To systematically assess the effect of degree of RNA integ-
rity on microarray data, RNA samples in each RIN group
were analyzed on Affymetrix GeneChip Rat Expression
230A arrays for both handling conditions. Most of the
global microarray quality metrics that are summarized in
Affymetrix report files were within normal ranges for the
27 samples with RIN ≥ 6. All samples had percent present
calls within 10% of the mean value (49%). The scale fac-
tors (SF) for all but one hybridization were within 2 SD of
the mean (SF 1–3) and all were within 3 SD of the mean.
All samples except one RIN 7 sample and 3 RIN 6 samples
in the F/T set had 3'/5' Gapdh ratios below the recom-
mended threshold of 3. The effect on 3'/5' Gapdh and 3'/
5' Actb ratios corresponded well with average cRNA tran-
script length (Table 1). The 3' boundaries of the target
sequences (TargetSeq) for the 5' Gapdh and Actb probe sets
are located about 883 and 855 nt, respectively, upstream
of the 3' end of their corresponding RefSeqs and span
about 1150 nt in length [see Additional file 1]. Targets
that are less than 878 nt in length on average (i.e. the F/T
RIN 6 samples) would be expected to exhibit significantly
reduced hybridization to these probe sets.
The quality metrics discussed so far are summary metrics
that provide an assessment or surrogate measure of the
overall integrity of the sample. Individual probe set sig-
nals may vary in their sensitivity to RNA degradation. To
visualize the effect of handling condition and degree of
RNA degradation on individual gene expression profiles,
we limited the comparison set to the genes that were most
affected by sample incubation (347 probe sets that were
changed by 2-fold or greater in at least 30% of all non-
control F/T or 37°C samples compared to zero time con-
trols). The relationship between the log2 ratio data for the
filtered sets of noncontrol samples from the F/T and 37°C
incubations was displayed by plotting the heatmap and
dendrograms resulting from average linkage hierarchical
clustering (Figure 3). The samples clustered primarily by
handling condition and then by degree of degradation. In
general, four different patterns of probe set responses are
visualized in the heat map. The majority of probe sets
showed a decrease in signal induced by degradation that
was independent of handling condition and observable in
even moderately degraded (RIN 8) samples. A second,
Table 1: RNA metrics associated with RIN value and RNA degradation method. Average values and standard deviations are reported 
for metrics associated with samples in each RIN class (n = 3).
Handling 
condition
RIN class RIN 28s/18s rRNA cRNA yield cRNA length 3'/5' GAPDH 3'/5' β-actin
F/T 9.5 9.5 ± 0.1 1.43 ± 0.15 86 ± 8 1923 ± 157 1.17 ± 0.06 1.70 ± 0.35
8 8.1 ± 0.2 1.00 ± 0.00a 63 ± 4b 1398 ± 116a 1.77 ± 0.21 1.93 ± 0.06
7 7.0 ± 0.1 0.70 ± 0.10a 44 ± 12a 1136 ± 207a 3.05 ± 0.95b 3.62 ± 1.18b
6 6.2 ± 0.1 0.50 ± 0.10a 38 ± 3a 878 ± 62a 5.50 ± 0.8a 5.27 ± 0.86a
37°C 9.5 9.5 ± 0.2 1.35 ± 0.13 74 ± 16 2294 ± 236 1.01 ± 0.02 1.34 ± 0.02
9 9.1 ± 0.1 1.33 ± 0.06 83 ± 7 2110 ± 322 1.24 ± 0.20 1.49 ± 0.26
8 8.2 ± 0.1 1.33 ± 0.06 61 ± 19 1834 ± 293 1.29 ± 0.18 1.60 ± 0.04
7 7.0 ± 0.2 1.07 ± 0.15b 42 ± 6 1210 ± 158a 2.00 ± 0.21a 2.12 ± 0.20a
6 6.1 ± 0.5 0.90 ± 0.10a 39 ± 18a 1244 ± 223a 1.96 ± 0.41a 2.29 ± 0.40a
aP < 0.01 compared to RIN 9.5 set
bP < 0.05 compared to RIN 9.5 setBMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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smaller cluster exhibited an increase in signal induced by
degradation by either method. The expression levels of a
third subset of genes were selectively altered by ex vivo
incubation at 37°C [see Additional File 2]. The 10 genes
in this cluster are primarily involved in cellular defense
responses like the mitogen activated protein kinase
(MAPK) pathway (Dusp1,  Hspa1a,  c-Jun), immune
response (Cxcl1), response to hypoxia (Egr-1) [12], cell
growth regulation (Btg2, Myd116, Bhlhb2) or other stress
responses (Zpf36, Slc25a25). Over expression of Zfp36,
Btg2, c-Jun, and Egr-1 has also been reported to occur in
surgically extirpated prostate tissue after 1 hr of warm
ischemia [13]. Dusp1 and Egr-1 are also 2 of 14 gene tran-
scripts that increased in peripheral blood mononuclear
cells prepared by Ficoll-Hypaque density centrifugation at
21°C compared to 8°C [14]. Independent confirmation
of an increase in Egr1 mRNA levels (5-fold after 1 and 3 hr
incubation at 37°C) was conducted using qRT-PCR (data
Hierarchical clustering of significantly changed genes from samples progressively degraded by different tissue handling condi- tions Figure 3
Hierarchical clustering of significantly changed genes from samples progressively degraded by different tissue 
handling conditions. Sample labels are concatenated from handling condition, time of incubation, RIN, and study code. Log2 
ratios calculated for each sample relative to the average of three zero-time controls are mapped on a green (-1) to red (1) 
color scale.BMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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not shown). A fourth cluster of 25 probe sets were selec-
tively decreased in signal after 2 hr ex vivo incubation at
37°C. More than 75% of these probe sets hybridize to
transcripts that are either highly expressed in immune
cells or involved in immune function [see Additional file
2]. Ex vivo incubation may have caused a selective loss in
the presence, function or integrity of immune cells in the
liver samples.
Characterization of probe set sensitivity to RNA 
degradation
The correlation between RNA degradation by F/T and
average cRNA length observed in Table 1 suggests that rel-
ative probe set position on a target reference sequence
may be a determinant of sensitivity to degradation. To
examine this further, probe sets were first identified that
showed a statistically significant difference in signal level
between RIN groups and a progressively increasing or
decreasing trend in average signal between RIN 9.5, 8, 7,
and 6 sets generated by F/T (INC or DEC, respectively).
Only probe sets that mapped to a single reference
sequence (RefSeq) transcript containing a terminal polyA
sequence  ≥ 10 nt were selected in order to accurately
measure probe set location relative to the reverse tran-
scription initiation site. Using these criteria, 89 DEC and
12 INC probe sets were identified. 61 probe sets were also
identified that were relatively invariant in signal as a func-
tion of RIN (INV).
For probe sets classified as INV or DEC, seven measure-
ments were made to characterize the location and length
of each probe set target sequence on its corresponding ref-
erence transcript sequence (Figure 4). The INC set was not
further characterized because of the small sample size. The
metrics were RefSeq length, TargetSeq length, TargetSeq
length/RefSeq length, 5'-3' distance (distance from 5' end
of the TargetSeq to the 3' end of the RefSeq), 3'-3' distance
(distance from 3' end of the TargetSeq to the 3' end of the
RefSeq), 5'-5' distance (distance from 5' end of the RefSeq
to the 5' end of the TargetSeq), and average RIN 9.5 signal.
A mean and standard deviation for each distance metric
was calculated within DEC or INV groups (Table 2). Indi-
vidual measurements for each probe set in the DEC and
INV groups are tabulated in Additional file 3.
The correlation between each distance metric and probe
set sensitivity to RNA integrity was examined in an
unpaired t-test comparison of DEC and INV probe set
metrics. Probe sets that decreased in signal as a function of
decreasing RNA integrity tended to be located signifi-
cantly farther from the 3' end of their target transcript
sequences than INV probe sets (P < 0.0001) (Table 2).
While average TargetSeq length did not significantly differ
between DEC and INV groups, DEC probes tended to map
to longer RefSeq transcripts and therefore had lower Tar-
getSeq Length/RefSeq Length ratios. DEC probe sets also
tended to be lower in signal in undegraded (RIN 9.5) sam-
ples than INV probe sets.
Unlike INV probe sets, the 5'-3' distances of DEC probe
sets were bimodally distributed with maxima near 650
and 1600 nt (Figure 5). The DEC probe sets were divided
into two groups with 5'-3' distances either less than or
greater than 1000 nt and analyzed further. The majority
(66/89) of DEC probe sets including
AFFX_Rat_GAPDH_5_at and AFFX_Rat_beta-actin_5_at
had 5'-3' distances > 1000 nt. All metrics that were signif-
icantly different for the DEC group as a whole were also
significantly changed for this subset. The 23 DEC probe
sets with 5'-3' distances < 1000 nt (which includes
AFFX_Rat_beta-actin_M_at) were significantly different
from INV probe sets in TargetSeq length, TargetSeq
Length/RefSeq Length, and average RIN 9.5 signal (Table
2).
Table 2: Distance metrics associated with probe set sensitivity to F/T RNA degradation. Probe sets were classified as invariant (INV) 
to degradation or as decreasing in signal (DEC) in response to degradation. DEC probe sets were further divided into two classes 
based on probe set location relative to the corresponding reference sequence termini.
Distance metric INV DEC DEC (5'-3' < 1000) DEC (5'-3' > 1000)
5'-3' distance 638 ± 386 1381 ± 665a 646 ± 171 1637 ± 576b
3'-3' distance 211 ± 388 973 ± 653a 289 ± 228 1212 ± 579b
5'-5' distance 1072 ± 783 904 ± 764 1250 ± 874 784 ± 689
RefSeq length 1711 ± 845 2285 ± 901a 1896 ± 830 2420 ± 891b
TargetSeq length 479 ± 72 451 ± 109 406 ± 111c 467 ± 105
TargetSeq/RefSeq 0.37 ± 0.21 0.22 ± 0.10a 0.25 ± 0.14c 0.21 ± 0.08b
Avg log2 RIN 9.5 signal 11.5 ± 1.3 10.0 ± 1.7a 10.0 ± 1.7c 10.1 ± 1.8b
C o u n t 6 18 92 36 6
aP < 0.0001 in unpaired two-tailed t-test comparisons of INV and DEC sets
bP < 0.001 in a Tukey's post-test comparison of a one-way ANOVA
cP < 0.01 in a Tukey's post-test comparison of a one-way ANOVABMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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Effect of level of RNA integrity on microarray performance
Sensitivity (the rate of detection of true positives among
all positives) and specificity (the rate of detection of true
negatives among all negatives) are important perform-
ance objectives for microarray experiments. In toxicoge-
nomic experiments that are designed to measure the effect
of time and dose level of treatment on gene expression,
misleading results can be generated by confounding vari-
ables such as RNA degradation, tissue sectioning, diurnal
effects, etc. The effect of RNA degradation on assay specif-
icity was measured by comparing control liver samples in
which RIN level was the independent variable. Statistical
Analysis of Microarrays (SAM) was applied at a median
false discovery rate (FDR) of 0.1 in two-sample compari-
sons of undegraded control liver RNA (RIN 9.5) with liver
samples of decreasing RIN value generated by F/T. Com-
parisons of RIN 9.5 samples with RIN 8 or 7 samples
yielded 16 or 255 false positives, respectively, using sig-
nals derived with either MAS5 or PLIER. A high number of
statistically significant changes in signal level were
observed for RIN 9.5 and RIN 6 sample comparisons
(9243 using PLIER and 4203 using MAS5).
The effect of RIN level on sensitivity was assessed using
receiver operating characteristic (ROC) plots that measure
diagnostic accuracy. ROC plots are generated by plotting
sensitivity (true positive fraction) versus 1-specificity
(false positive fraction) along a continuum of decision
thresholds (P-value cutoffs). Known gene expression
changes were modeled in silico using a mixed tissue para-
digm designed to measure microarray performance [15].
Two mixtures composed of different proportions of rat
testis, brain, liver, and kidney RNA are the components of
a reference material that has signal ratios of 1:4, 2:1, 3:2,
and 1:1 in tissue-selective probe sets. This mixed tissue
RNA design can be effectively modeled in silico from array
data for each tissue RNA component in the mixture.
Microarray signal data from rat liver RNA with different
levels of RNA integrity (RIN 9.5, 8, 7, or 6) generated by
F/T, was combined in silico with signal data from rat brain,
testis, and kidney RNA. Assay sensitivity for detecting a
true positive fold change of 1.5-, 2-, or 4-fold at a fixed
false positive rate of 10% was calculated for each RNA
quality level from data modeled with proportional differ-
ences in liver-selective (LS) signal and a 1:1 ratio of kid-
ney-selective (KS) signal. These calculations were made
using the entire set of 292 LS probe sets unselected for sen-
sitivity to RNA degradation (LS_ALL) or subsets of probe
sets that either significantly decrease (LS_DEC) or are
invariant in signal (LS_INV) as a function of RNA quality
as true positives and 188 KS probe sets as true negatives
(Table 3).
Assay sensitivity was markedly decreased by the use of
LS_DEC or LS_ALL probe sets as analytes for detecting
modeled changes of 1.5-, 2-, and 4-fold as a function of
RIN level. The effect was most pronounced for LS_DEC
probes, for 1.5-fold change detection, and for RNA quality
of RIN ≤ 7. ROC plots that used LS_INV probe sets as ana-
lytes showed no change in sensitivity as a function of
either RIN level or fold change detection.
Discussion
In this study, it was observed that time after thawing had
a greater effect on RNA integrity than time of incubation
of liver tissue after surgical removal at either room temper-
ature or 37°C (Figure 1). Freezing disrupts tissue struc-
ture, rendering the tissue highly sensitive to RNA
degradation. In contrast, autolysis of fresh liver tissue
appeared to be a much slower process. To minimize the
potential impact of RNA degradation on microarray data,
Histogram of 5'-3' distances for probe sets with different  responses to RNA degradation Figure 5
Histogram of 5'-3' distances for probe sets with dif-
ferent responses to RNA degradation. 5'-3' distances 
for probe sets that are INV (grey) or DEC (black) are plotted 
as a fraction of the total number in each set.
Probe set distance metrics Figure 4
Probe set distance metrics. Illustration of distance met-
rics for a hypothetical probe set (vertical open bars) in rela-
tion to the 5'- and 3'-termini of the corresponding RefSeq 
(solid horizontal bar).BMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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resected tissue should be sectioned and either flash frozen
or immersed in a tissue stabilization solution such as
RNALater. Archived frozen tissue should be quickly dis-
rupted and homogenized in denaturing solutions after
removal from storage. Homogenization can be performed
more rapidly if tissue is cut into smaller sections prior to
freezing.
Although ex vivo incubation of tissue for several hours had
little effect on RNA integrity, it did induce changes in the
expression of ischemia-induced and early immediate
genes, as has been reported by others [13,16,17]. Many
inflammatory response gene transcripts are inherently
unstable as a mechanism to control cellular response to
certain stimuli [18]. The increases in signal observed with
37°C incubation could result from de novo transcription
or stabilization of labile mRNAs through, for example, the
activation of MAPK or other signaling pathways [19].
Incubation of liver sections at 37°C also induced a selec-
tive decrease in a set of genes associated with immune
function. Delay in sample processing has been observed
to cause a decrease in the levels of selective transcripts in
blood cells [16]. Alternatively, this result could have
arisen from selective loss of an immune cell population in
liver through diffusion or autolysis.
A majority (≥ 75%) of the probe set signals identified as
most sensitive to sample incubation at 37°C or after thaw-
ing (see Figure 3) are expressed in whole tissue RNA prep-
arations from brain, kidney, and heart in addition to liver
(data not shown). Although differences in the kinetics of
postmortem RNA degradation have been observed
between tissue types [20], it is anticipated that signals for
most of these 347 probe sets would also be sensitive to
sample integrity in these other tissues. Similarly designed
studies using other tissues may identify additional probe
sets that are sensitive to sample integrity but not expressed
in rat liver.
A subtle but reproducible difference in the relationship
between RIN value and qualitative (electrophoretic trac-
ings) or other quantitative RNA metrics (28s/18s rRNA
ratio, cRNA yield, and cRNA length) was observed
between samples generated by different tissue handling
methods (Table 1 and Figure 2). The method of degrading
RNA may release or activate ribonucleases with different
specificities or differentially affect ribonuclease access to
substrate. For example, ribonucleases 1 and 4 have differ-
ent pH optima and substrate preferences for poly(C) and
poly(U) [21]. Freeze/thaw may be the more relevant
method of inadvertent sample degradation associated
with toxicogenomic studies. The correlations observed
here between RIN levels generated by F/T of liver tissue
and other sample quality metrics may not necessarily be
applicable for other mechanisms of RNA degradation
(e.g., the introduction of exogenous RNase during han-
dling) or for other tissues. For example, a threshold RIN
value of 7.8 has been recently proposed for optimal RNA
reliability for analysis of human tumor samples on
Affymetrix GeneChip arrays, where reliability was defined
as a 3'/5' Gapdh ratio threshold ≤ 1.25 [10]. In our study,
only samples with RIN ≥ 9 had 3'/5' Gapdh ratios ≤ 1.25.
More interlaboratory studies are needed to evaluate the
reproducibility of RIN and its correlation to performance
on multiple array formats before a RIN threshold can be
recommended as a component of best practices for micro-
array data generation. The advantage to RIN as a metric is
that it is an automated measurement made prior to per-
forming expensive in vitro transcription (IVT) assays and
array hybridizations. Although average cRNA length cor-
related well with microarray sample quality in this study,
Table 3: Effect of RIN and probe sensitivity to RNA degradation on assay sensitivity. The percent sensitivity for a false positive rate of 
10% [and 95% Confidence Interval] is reported for liver selective probe sets that significantly decrease in response to RNA degradation 
(LS_DEC), all liver selective probe sets (LS_ALL), and liver selective probe sets that are invariant to RNA degradation (LS_INV).
Fold change RIN group LS_DEC LS_ALL LS_INV
1.5 9.5 97.2 [85.8, 99.7] 92.9 [88.2, 96.1] 100 [94.0, 100]
8 92.4 [78.7, 98.1] 92.0 [87.5, 95.2] 100 [93.6, 100]
7 72.7 [55.2, 85.9] 88.7 [82.0, 93.4] 100 [90.3, 100]
6 68.4 [51, 82.5] 88.3 [82.9, 92.4] 100 [84.5, 100]
2 9.5 99.2 [90.7, 100] 96.3 [93.3, 98.1] 100a
8 94.3 [82.6, 98.7] 94.7 [91.6, 96.8] 99.9 [80.3, 100]
7 84.2 [68.7, 93.6] 93.8 [89.4, 96.7] 100 [39.5, 100]
6 83.6 [68.3, 93.1] 93.3 [89.3, 96.0] 100 [79.7, 100]
4 9.5 99.0 [89.3, 100] 96.9 [94.5, 98.4] 100a
8 96.4 [85.8, 99.4] 95.7 [93.1, 97.5] 100a
7 87.8 [74.1, 95.4] 95.3b 100a
6 87.6 [74.2, 95.2] 94.6 [91.6, 96.7] 100a
aNo CI (for perfect discrimination, data cannot be fitted to a ROC curve)
bValue interpolated from empirical data using Weibull cumulative discrimination functionBMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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this value is currently not an automated measurement
that is calculated by Agilent Bioanalyzer software and
needs to be estimated from electropherograms by the end
user.
The primary effect of RNA degradation on samples ana-
lyzed on microarrays was a decrease in the average length
of products that are reverse transcribed and amplified
using T7 polymerase. The multiple rounds of in vitro tran-
scription that are used to generate samples from small
amounts of RNA from biopsies or laser-captured micro-
dissections also induce a decrease in transcript cRNA yield
and length [1]. Amplifying target from small samples was
associated with a loss of signal for gene transcripts with
high GC content and with a greater number and length of
predicted hairpin formations [22]. We did not observed
any difference in GC content between probe sets that were
most and least sensitive to RNA degradation generated by
F/T in rat liver (data not shown).
A relatively small percentage (~4%) of probe sets that are
on RAE230A arrays and expressed in liver were found to
be similar in sensitivity to cRNA target length as the 5'-
probe sets for Gapdh or Actb. Of the probe sets with this
sensitivity that also had verifiable transcription termini,
most (~75%) were located more than 600 nt upstream of
the 3'-end of their target sequences. For the remaining
DEC probe sets that were located within the designed
probe selection region, no other measure of probe set
length or location was identified that was significantly dif-
ferent from INV probe sets and could explain the
enhanced sensitivity to RNA degradation.
In comparisons of probe set level signal data from unde-
graded (RIN 9.5) RNA with RNA of progressively decreas-
ing RNA integrity (RIN 8, 7, or 6), a substantial increase in
the rate of detection of false positives was observed when
RIN values are ≤ 7. Comparisons of samples with different
RIN levels could occur in toxicogenomic studies where
treatment conditions have induced a degree of damage
and vehicle-treated control tissue is unaffected. Similar
effects are possible in comparisons of results between sin-
gle and multiple rounds of amplification. In one study,
protocol method (one-cycle or two-cycle) was shown to
have a bigger effect on signal variance than tissue type
(breast vs. cervix) [3]
In our analysis of the effect of RNA integrity on assay sen-
sitivity, probe set level signals from both "control" and
"treated" samples were modeled from RNA with the same
RIN. This design interrogates a decrease in sensitivity in
studies where RNA integrity is similar for all samples but
at lower than optimal levels because of tissue handling or
RNA isolation method. The accuracy of true positive
detection of in silico modeled changes of 1.5-, 2-, and 4-
fold was reduced for RNA samples with RIN values ≤ 7.
The effect was greatest for probe sets most sensitive to
sample integrity and was less pronounced for probe sets
unselected for an effect of RNA degradation on signal
level.
Conclusion
In this paper, we examined the effect of sample integrity
on microarray performance through the use of samples
with a progressive decrease in RNA quality that was
indexed using a sensitive automated metric of RNA degra-
dation (RIN). We identified a RIN threshold beyond
which we observed a decrease in assay specificity and sen-
sitivity. The effect on assay performance could be linked to
a decrease in hybridization of target to probe sets that map
more than 600 nt upstream of the transcription termini
on their corresponding reference sequences.
Methods
Animal studies
Male Sprague Dawley rats were received from Harlan Lab-
oratories (Frederick, MD) at 6 weeks of age and accli-
mated for 6 days. The rats received certified rodent diet
#5002C (Purina Mills Inc.) ad lib and drinking water puri-
fied by reverse osmosis. The animals were on a 12 hr light/
dark cycle and euthanasia was performed within 4 to 6 hr
after the start of the light cycle. Animal care and proce-
dures were approved by the Institutional Animal Care and
Use Committee at the US FDA.
Sample generation
After euthanasia by carbon dioxide inhalation, whole liv-
ers were removed and placed in Petri dishes containing
sterile phosphate buffered saline (PBS). Livers were briefly
rinsed with PBS to remove blood. Liver sections were pre-
pared by removing a 2 cm square section from the left lat-
eral lobe and further sectioning it into 12–16 equal pieces.
Each time course study used a single liver lobe from a
unique animal. For room temperature incubations, the
sections were placed in RNAlater (Ambion, Austin, TX) at
the end of each incubation period. Incubations at 37°C
were performed in a water bath and terminated by addi-
tion of RNAlater. After the samples were incubated in
RNAlater overnight, RNA was isolated using Qiagen Midi
kits (Qiagen, Valencia, CA). To generate samples in which
RNA was degraded after tissue thawing, liver sections were
snap frozen in a dry ice/ethanol slurry and stored at -
70°C. Random tissue sections were thawed at room tem-
perature for various intervals. At the end of each incuba-
tion period, samples were homogenized in Qiagen RLT
buffer and processed following the Qiagen Midi kit proto-
col. RNA and cRNA yields were quantitated on a Nano-
Drop ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE). All samples had 260/280
ratios ≥ 2.0. RNA integrity was characterized by measuringBMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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the 28s/18s rRNA ratio and RIN on an Agilent 2100 Bio-
analyzer (Santa Clara, CA). RIN values for the zero-time
point samples were ≥ 9.
cRNA was synthesized from 5 µg total RNA using Affyme-
trix standard protocols for cDNA synthesis and an IVT
labeling kit from Enzo Life Sciences (Farmingdale, NY) for
synthesis of biotin-labeled cRNA. Average cRNA lengths
were calculated from standard curves generated from run-
ning the RNA 6000 Ladder (Ambion) on an Agilent 2100
Bioanalyzer and enabling smear analysis in the Agilent
2100 Expert software. A region was defined for each smear
and the region start size was manually aligned with the
vertical point of symmetry for each electropherogram. The
region start sizes were automatically extrapolated from the
standard curve data obtained from the 25 nt marker peak,
and the first 5 RNA ladder fragment peaks in the RNA
6000 Nano Assay. The region end size and other values of
the smear analysis table were not used to determine the
median cRNA length.
To calculate statistically significant changes in RNA met-
rics between samples with RIN 9.5 and samples with RIN
< 9.5, one-way ANOVA with a Dunnett's post test was per-
formed using GraphPad Prism version 3.00 for Windows
(GraphPad Software, San Diego, CA).
Microarray experiments
Thirtytwo RNA samples from 7 independent time course
studies of RNA degradation by F/T or 37°C incubation
were labeled as described above and run on Affymetrix
RAE230A arrays. 15 µg of fragmented cRNA was hybrid-
ized per array. Probe set signals were calculated using the
Affymetrix MAS5 algorithm from files scaled to a target
signal value of 500. The microarray data is available in EBI
ArrayExpress under the accession number E-MEXP-1069
[23].
Cluster analysis
Log2 signal ratios were calculated for probe sets in each
non-control sample relative to the average zero-time con-
trol signal for each handling condition. Probe sets were
identified that were either present in all control samples
(n = 8) and had log2 ratios ≤ -1 in at least 50% of non-con-
trol 37°C or F/T samples or were present in all non-con-
trol samples within a handling condition set and had log2
ratios ≥ 1 in at least 30% of non-control 37°C or F/T sam-
ples. A total of 347 probe sets met these criteria within F/
T or 37°C datasets. Hierarchical clustering was performed
on this subset of probe sets for 28 non-control samples
using Spotfire DecisionSite Functional Genomics software
(Spotfire, Inc., Somerville, MA), Pearson correlation for
the similarity measure, and the unweighted average clus-
tering method. Gene Ontology classification was per-
formed using DAVID [24].
Probe set characterization
Probe sets that were significantly increased (INC),
decreased (DEC), or unchanged (INV) by degradation
were identified using the F/T RIN group replicates. Probe
sets were identified as differentially expressed among the
four RIN classes (9.5, 8, 7, and 6) by applying a multivar-
iate permutation test (SAM) to provide a median false dis-
covery rate of 10% using BRB-Array Tools Version 3.5.0
developed by Dr. Richard Simon and Amy Peng Lam.
From this list of 574 probe sets, subsets of INC and DEC
probe sets were identified that demonstrated a consist-
ently increasing or decreasing monotonic trend in average
signal between RIN 9.5, 8, 7 and 6 groups. From the probe
sets that were not identified as significantly changed
between RIN classes by SAM, a subset of INV probe sets
were identified with signal values that did not signifi-
cantly change as a function of RIN (signal coefficients of
variation (CV) < 0.01 across all 12 F/T samples) and did
not show a monotonic trend in average signal as a func-
tion of RIN.
Probe set location relative to the 5' and 3' ends of tran-
script reference sequences was calculated for DEC and INV
probe sets that could be mapped to a single mRNA refer-
ence sequence (RefSeq) containing a terminal polyA
sequence  ≥ 10 nt. Mapping was defined as a 100%
sequence match between the corresponding RefSeq and
the first (No. 1) and last (No. 11) perfect match (PM)
probes in the 11 probe series that comprises each probe
set. The minimum contiguous sequence of a RefSeq that is
targeted by all 11 probe pairs in a probe set is defined as
the target sequence (TargetSeq).
Three distance metrics (3'-3' distance, 5'-3' distance, and
5'-5' distance) were determined for each probe set relative
to its mapped position on the corresponding RefSeq. Ref-
Seq lengths used for distance metrics excluded the length
of the polyA sequence. The statistical significance of dis-
tance metric data between INV and DEC groups was cal-
culated in unpaired two-tailed t-test comparisons using
GraphPad Prism version 3.00 for Windows (GraphPad
Software, San Diego, CA). The statistical significance of
distance metric data between INV, DEC (5'-3' distance <
1000 nt), and DEC (5'-3' distance > 1000 nt) groups was
calculated by applying a Tukey's post-test comparison of a
one-way ANOVA using GraphPad software.
Effect of RNA degradation on false positive and false 
negative rates
The effect of RNA degradation on the generation of false
positives was analyzed by applying SAM at a median FDR
of 0.1 in two-sample comparisons of control liver RNA
that differed in RIN value using BRB-ArrayTools v3.5.0.
Signals from the 3 F/T RIN 9.5 samples were compared to
F/T RIN 8, 7, or 6 sample sets. For this analysis, signalsBMC Biotechnology 2007, 7:57 http://www.biomedcentral.com/1472-6750/7/57
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were calculated using MAS5 or PLIER in ArrayAssist v4.0
(Stratagene, La Jolla, CA) for each comparison group of 6.
Probe sets with tissue-selective expression were identified
from body map data generated on RAE230A arrays by
applying a tissue-selective index cutoff of 5, as previously
described [15]. Using this criterion, 292 probe sets with
liver-selective signals (LS_ALL) and 188 probe sets with
kidney-selective (KS) signals were identified. A subset of
30 LS probe sets (LS_DEC) was identified that were signif-
icantly changed by RNA degradation by applying SAM at
a median FDR of 0.2 and that had decreasing monotonic
trends in average log2 signal between the 4 F/T RIN groups
(9.5 to 6). From the remaining LS probe sets that did not
show a statistically significant difference in signal level
between RIN groups using SAM, a set of 33 invariant
probe sets (LS_INV) was identified that had log2 signals
with CV ≤ 0.01 and a lack of monotonic trend in average
signal across the 4 RIN groups ordered by decreasing RNA
quality.
To model the effect of liver degradation on the diagnostic
accuracy of detecting 1.5-fold changes in expression, the
signal intensity from each F/T sample was used as the liver
component to derive in silico signal intensities for the tis-
sue-selective probe sets used as analytes in each of the two
mixtures (Mix1 and Mix2) that comprise a mixed tissue
RNA reference material using the formulas in [15]. "Bio-
logical" replicates of the modeled probe set signals in
Mix1 and Mix2 were calculated for RIN group replicates
through the use of a different, randomly assigned inde-
pendent preparation of pooled brain, kidney, and testis
RNA as the complex background (Batches 1–3 in [15]) for
each replicate. To model the effect on diagnostic accuracy
of 2-fold and 4-fold changes, the proportion of liver RNA
signal in the mixtures was interchanged with the brain
and testis RNA signal proportions, respectively. For each
set of 3 RIN group replicates, a two sample t-test compar-
ison of modeled Mix1 and Mix2 log2 signal values was
performed to calculate a P value for each analyte. Subsets
of LS_DEC, LS_INV, or LS_ALL analytes were used as true
positives and the set of KS analytes were used as true neg-
atives in ROC plots. The web-based program JROCFIT
[25] was used to calculate the sensitivity at a 10% false
positive rate from ROC plots of fitted data using the fre-
quency of positives and negatives found in each of 36
exponentially spaced P value bins from 1 to 10-7 (format
3). Where the data could not be fitted to a curve using
JROCFIT, the sensitivity was interpolated from empirical
data using the Weibull cumulative distribution function
in Microsoft Excel.
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